Current status of prognostic factors in patients with metastatic renal cell carcinoma.

Teishima, Jun; Inoue, Shogo; Hayashi, Tetsutaro; Matsubara, Akio

Teishima, Jun; Inoue, Shogo; Hayashi, Tetsutaro; Matsubara, Akio.

Affiliation

Teishima J; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Inoue S; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Hayashi T; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Matsubara A; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Int J Urol ; 26(6): 608-617, 2019 06.

Article in En | MEDLINE | ID: mdl-30959579

Subject(s)

Carcinoma, Renal Cell/pathology; Carcinoma, Renal Cell/therapy; Kidney Neoplasms/pathology; Kidney Neoplasms/therapy; Protein Kinase Inhibitors/therapeutic use; TOR Serine-Threonine Kinases/antagonists & inhibitors; Biomarkers, Tumor; C-Reactive Protein/metabolism; Cytoreduction Surgical Procedures; Humans; Immunotherapy; Lymphocyte Count; Models, Biological; Molecular Targeted Therapy; Neoplasm Metastasis; Nephrectomy/methods; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors

Key words

C-reactive protein; biomarker; metastatic renal cell carcinoma; prognostic factor; targeted therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Protein Kinase Inhibitors / TOR Serine-Threonine Kinases / Kidney Neoplasms Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Urol Journal subject: UROLOGIA Year: 2019 Type: Article Affiliation country: Japan

Fulltext

XML

PubMed Links

Search on Google